Wall Street Analysts See a 25.51% Upside in AxoGen (AXGN): Can the Stock Really Move This High?

AxoGen (AXGN) closed the last trading session at $12.35, gaining 32.4% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $15.50 indicates a 25.5% upside potential.The average comprises six short-term price targets ranging from a low of $12 to a high of $20, with a standard deviation of $2.74. While the lowest estimate indicates a decline of 2.8% from the current price level, the most ...